Onno W Akkerman
Overview
Explore the profile of Onno W Akkerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Casco N, Jorge A, Palmero D, Alffenaar J, Fox G, Ezz W, et al.
Eur Respir J
. 2023 Oct;
62(5).
PMID: 37827576
Background: Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and...
12.
Niewold P, Dijkstra D, Cai Y, Goletti D, Palmieri F, van Meijgaarden K, et al.
Sci Rep
. 2023 Jul;
13(1):11617.
PMID: 37464009
Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6 million new cases annually. Discriminating TB disease from differential diagnoses can be complex, particularly in the...
13.
Akkerman-Nijland A, Rottier B, Holstein J, Winter R, Touw D, Akkerman O, et al.
ERJ Open Res
. 2023 Jun;
9(3).
PMID: 37377654
https://bit.ly/40oOMIn.
14.
Vanino E, Granozzi B, Akkerman O, Munoz-Torrico M, Palmieri F, Seaworth B, et al.
Int J Infect Dis
. 2023 Mar;
130 Suppl 1:S12-S15.
PMID: 36918080
In December 2022 World Health Organization released a new treatment for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) guideline. The main novelty of this update is two new recommendations (i) a 6-month treatment regimen...
15.
Espinosa-Pereiro J, Ghimire S, Sturkenboom M, Alffenaar J, Tavares M, Aguirre S, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678638
Previous clinical trials for drug-susceptible tuberculosis (DS-TB) have shown that first-line treatment with doses of rifampicin up to 40 mg/kg are safe and increase the early treatment response for young...
16.
Ghimire S, Iskandar D, van der Borg-Boekhout R, Zenina M, Bolhuis M, Kerstjens H, et al.
Eur Respir J
. 2022 Nov;
60(6).
PMID: 36356974
No abstract available.
17.
Kuhlin J, Sturkenboom M, Ghimire S, Margineanu I, van den Elsen S, Simbar N, et al.
J Mass Spectrom Adv Clin Lab
. 2022 Aug;
25:72.
PMID: 36035622
[This corrects the article DOI: 10.1016/j.clinms.2018.10.002.].
18.
Saderi L, Puci M, Lorenzo B, Centis R, DAmbrosio L, Akkerman O, et al.
Arch Bronconeumol
. 2022 Aug;
58(12):809-820.
PMID: 35945071
Introduction: No previous systematic reviews have comprehensively investigated the features of Xpert MTB/XDR and other rapid tests to diagnose pre-XDR/XDR-TB. The aim of this systematic review is to assess existing...
19.
Eskandari S, Akkerman O
Lancet Infect Dis
. 2022 Jul;
22(8):1252.
PMID: 35870469
No abstract available.
20.
Roosma E, van Gemert J, de Zwart A, Van Leer-Buter C, Hellemons M, Berg E, et al.
J Heart Lung Transplant
. 2022 Jul;
41(9):1237-1247.
PMID: 35843852
Background: Concerns have been raised on the impact of coronavirus disease (COVID-19) on lung transplant (LTx) patients. The aim of this study was to evaluate the transplant function pre- and...